Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters
- PMID: 24493370
- PMCID: PMC4146750
- DOI: 10.1007/s11682-014-9291-2
Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters
Abstract
The clinical relevance of gray/white matter contrast ratio (GWR) in mild cognitive impairment (MCI) remains unknown. This study examined baseline GWR and 3-year follow-up diagnostic status in MCI. Alzheimer's Disease Neuroimaging Initiative MCI participants with baseline 1.5 T MRI and 3-year follow-up clinical data were included. Participants were categorized into two groups based on 3-year follow-up diagnoses: 1) non-converters (n = 69, 75 ± 7, 26 % female), and 2) converters (i.e., dementia at follow-up; n = 69, 75 ± 7, 30 % female) who were matched on baseline age and Mini-Mental State Examination scores. Groups were compared on FreeSurfer generated baseline GWR from structural images in which higher values represent greater tissue contrast. A general linear model, adjusting for APOE-status, scanner type, hippocampal volume, and cortical thickness, revealed that converters evidenced lower GWR values than non-converters (i.e., more degradation in tissue contrast; p = 0.03). Individuals with MCI who convert to dementia have lower baseline GWR values than individuals who remain diagnostically stable over a 3-year period, statistically independent of cortical thickness or hippocampal volume.
Figures


References
-
- Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279. - PMC - PubMed
-
- Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex in patients with Alzheimer's disease. Cerebral Cortex. 1991;1:103–116. - PubMed
-
- Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage. 2001;14:298–309. - PubMed
Publication types
MeSH terms
Grants and funding
- CAPMC/ CIHR/Canada
- R01 HL111516/HL/NHLBI NIH HHS/United States
- R01-AG034962/AG/NIA NIH HHS/United States
- R01-NR010827/NR/NINR NIH HHS/United States
- K12 HD043483/HD/NICHD NIH HHS/United States
- T35-AG038027/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- R01 AG034962/AG/NIA NIH HHS/United States
- T35 AG038027/AG/NIA NIH HHS/United States
- K01 AG030514/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U19 AG010483/AG/NIA NIH HHS/United States
- U54 HD083211/HD/NICHD NIH HHS/United States
- U19 AG024904/AG/NIA NIH HHS/United States
- R01-HL111516/HL/NHLBI NIH HHS/United States
- K23 AG030962/AG/NIA NIH HHS/United States
- K24-AG046373/AG/NIA NIH HHS/United States
- K24 AG046373/AG/NIA NIH HHS/United States
- R01 NR010827/NR/NINR NIH HHS/United States
- K23-AG030962/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous